Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Cerilliant
Merck
QuintilesIMS
Federal Trade Commission
Boehringer Ingelheim
Dow
Argus Health
US Army
Teva

Generated: August 19, 2017

DrugPatentWatch Database Preview

RENOVIST II Drug Profile

« Back to Dashboard

Which patents cover Renovist Ii, and when can generic versions of Renovist Ii launch?

Renovist Ii is a drug marketed by Bracco and is included in one NDA.

The generic ingredient in RENOVIST II is diatrizoate meglumine; diatrizoate sodium. There are nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the diatrizoate meglumine; diatrizoate sodium profile page.

Summary for Tradename: RENOVIST II

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:RENOVIST II at DailyMed

Pharmacology for Tradename: RENOVIST II

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco
RENOVIST II
diatrizoate meglumine; diatrizoate sodium
INJECTABLE;INJECTION010040-019Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Argus Health
Deloitte
Colorcon
Chinese Patent Office
AstraZeneca
Moodys
Covington
Farmers Insurance
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot